Analysis from the bioinformatics website Gene Expression Profiling Interactive Analysis (GEPIA) (http://gepia2.cancer-pku.cn/#index) shows that RASIP1 is highly expressed in clinical DLBCL specimens, compared with normal blood samples (shown in Figure 1a), suggesting that RASIP1 may serve as a tumorigenic molecule during DLBCL development. Here, RASIP1 is linked to diffuse large B-cell lymphoma.